Aged Garlic Extract: Benefits, Dosage & Safety (UK Guide)

Aged Garlic Extract (AGE) is a odourless, water-soluble form of garlic produced by storing raw cloves in dilute ethanol for up to twenty months. That slow ageing process converts harsh, unstable sulphur compounds into stable antioxidant molecules — most notably S-allylcysteine (SAC). It is ingredient five of 42 in KōJō Daily Formula, included at 600 mg of dry extract powder per serving. The research base is genuinely interesting, though I'll be upfront: most of the human trials are small, and large-scale RCT data remains limited.

What is Aged Garlic Extract?

Fresh garlic gets most of its pungency — and some of its biological activity — from allicin, a volatile compound that forms when a clove is cut or crushed. The problem with allicin is that it is chemically unstable: it degrades quickly, absorbs inconsistently across individuals, and is responsible for the breath and body odour that puts many people off garlic supplements altogether. Aged Garlic Extract sidesteps this by skipping allicin almost entirely. The long cold-ageing process converts allicin precursors into a different family of compounds — principally SAC, S-allylmercaptocysteine (SAMC), and a range of fructooligosaccharides — that are water-soluble, stable, and odourless.

In the body, SAC is the compound that has attracted the most scientific attention. It is readily absorbed from the gut, detectable in plasma within hours of ingestion, and appears to act primarily as a free-radical scavenger — meaning it may donate electrons to neutralise reactive oxygen species before they can damage cell membranes, proteins, or DNA. SAC also appears to interact with pathways involved in inflammatory signalling, though the precise mechanisms in living humans are still being characterised, as noted in a 2025 review of macrophage biology by Karasaki (2025).

In supplement form, AGE is typically sold as a dry extract powder — the form used in KōJō Daily Formula. Standardising to SAC content is the most meaningful quality marker to look for on a label, because it is SAC that most of the mechanistic and clinical research has focused on. A product that simply says "garlic powder" is a different thing entirely.

Clinical Evidence

The cardiovascular signal is where the human data is most developed, though still far from definitive. Garlic preparations have been studied in relation to blood pressure for decades. A 2016 review of nutraceuticals for blood pressure management by Sirtori et al. (2016) identified garlic as one of the more consistently studied plant-derived compounds in this context, with some trials suggesting modest reductions in systolic pressure — though the authors were careful to note that effect sizes across trials are variable and that the evidence does not yet support garlic as a standalone antihypertensive intervention.

One area where AGE specifically (rather than raw garlic) has attracted RCT interest is coronary artery calcification. A systematic review by Murali et al. (2024) examined randomised clinical trials testing interventions against cardiovascular calcification progression. The review included trials of AGE and noted that some studies reported slower progression of coronary calcium scores in the AGE group compared to placebo — a potentially meaningful finding, though the authors flagged that sample sizes were small and follow-up periods varied considerably between trials.

The antioxidant properties of AGE have been described since at least the early 2000s. Borek (2001) reviewed the evidence and concluded that AGE may act as a potent antioxidant, with SAC and related compounds appearing to scavenge reactive oxygen species and may reduce markers of oxidative stress in both animal and early human studies. The honest caveat here is that "antioxidant activity measured in a lab" does not automatically translate into a meaningful clinical outcome in a person — a distinction the supplement industry has historically been poor at making.

The historical relationship between garlic and cardiovascular health is long. Rahman (2001) traced garlic's medicinal use across Egyptian, Greek, Roman, and Ayurvedic traditions, and noted that modern pharmacological work has attempted to identify the specific compounds responsible for observed effects on platelet aggregation, lipid profiles, and vascular tone. What that history tells us is that garlic has been taken seriously as a cardiovascular food for millennia — what it does not tell us is which form, dose, or preparation delivers the most reliable effect in a modern clinical context.

There is also early-stage research into AGE and neurological health. Chauhan (2006) reviewed garlic's potential relevance to Alzheimer's disease, noting that SAC may reduce amyloid-beta-induced oxidative stress in cell and animal models. Frank et al. (2006) similarly reviewed antioxidant compounds in the context of Alzheimer's pathology and identified AGE as one of several plant-derived antioxidants with preliminary mechanistic interest. I want to be clear: this is very early-stage science. There are no large human RCTs demonstrating that AGE prevents or slows cognitive decline. The mechanistic hypothesis is plausible; the clinical proof is not there yet.

A 2023 study protocol by Chaliha et al. (2023) registered a randomised, double-blind, placebo-controlled trial investigating a combination of L-arginine and AGE for migraine prevention — an indication that researchers consider AGE worth testing in a rigorous design. The trial protocol itself is not a result, but it reflects growing interest in AGE within the clinical research community. Meanwhile, a 2020 review by Vlachojannis et al. (2020) described the clinical effectiveness of odourless garlic preparations as "preliminary" — a word I think is fair and worth keeping front of mind when reading any AGE marketing.

Dosage: What Research Supports

Clinical trials have used a fairly wide range of AGE doses, typically between 600 mg and 2,400 mg per day of standardised dry extract. The cardiovascular calcification trials reviewed by Murali et al. (2024) generally used doses in the 1,200 mg range, while some blood pressure studies have used doses as low as 600 mg daily. There is no EFSA-approved health claim for AGE and therefore no official reference intake in the way there is for, say, vitamin D or magnesium. The NHS does not publish a recommended daily amount for garlic extract supplements.

What the literature suggests is that 600 mg of standardised AGE dry extract per day sits at the lower end of the clinically studied range — which is not the same as saying it is ineffective at that dose, but it does mean the most dramatic effects in trials were often seen at higher amounts. The trade-off in a multi-ingredient daily formula is always dose versus breadth: including 42 active ingredients at meaningful amounts requires making considered choices about how much of each to include, rather than simply maximising every single one.

KōJō Daily Formula provides 600 mg of AGE dry extract powder per serving. That dose aligns with the lower end of what has been tested in human studies and reflects a practical decision about formulation space. If you are specifically targeting cardiovascular outcomes and want to trial higher doses, a standalone AGE supplement may be more appropriate — and I would encourage you to discuss that with a GP or registered dietitian first.

How KōJō Uses Aged Garlic Extract

I chose dry extract powder over raw garlic powder for two reasons: standardisation and tolerability. Dry extract powder allows us to specify a consistent SAC content batch to batch, which means the dose you read on the label reflects what is actually in the capsule. Raw garlic powder does not offer that consistency. The odourless nature of AGE also matters in a daily supplement — nobody wants to open their bag at the office and be greeted by the smell of a kitchen.

Within the KōJō Daily Formula, AGE sits alongside other ingredients with antioxidant and cardiovascular-adjacent research profiles. The formulation rationale is not that these ingredients "work together" in some mystical way — it is simply that a well-rounded daily formula should cover multiple evidence-supported areas of health, and AGE has a credible enough research base to earn its place as ingredient five of 42. The 600 mg dose is honest about what the evidence supports at a population level in a multi-ingredient context.

Safety and Considerations

AGE has a reasonable safety record in the published literature. The most commonly reported side effects from garlic supplements in general — including raw garlic preparations — are gastrointestinal: nausea, bloating, and loose stools, particularly on an empty stomach. AGE tends to produce fewer of these effects than raw garlic or allicin-releasing preparations, which is one of its practical advantages. The more significant safety consideration is drug interaction. Macan et al. (2006) studied AGE in patients on warfarin therapy and found no statistically significant changes in INR (International Normalised Ratio) in their small sample — suggesting AGE may be safer than raw garlic for anticoagulated patients — but the study involved only 48 participants and the authors explicitly described the findings as preliminary. If you are taking any anticoagulant or antiplatelet medication, speak to your GP before adding any garlic preparation to your routine.

Consult a healthcare professional before starting Aged Garlic Extract if you are pregnant, breastfeeding, taking medication, or have an underlying condition. A 2024 mini-review by Fejes et al. (2024) noted that while garlic is generally well tolerated in food amounts, supplemental doses warrant more caution, particularly in populations with existing health conditions. KōJō Daily Formula provides 600 mg of dry extract powder per serving — stay within the single-serving guidance.

Frequently asked questions

This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.